Mixor (Telmisartan, Amlodipine Besilate)

Telmisartan blocks the AT1 receptor for angiotensin II, preventing the hormone from causing vasoconstriction and aldosterone release. This results in relaxed blood vessels and reduced fluid retention, contributing to lower systemic blood pressure.

The dose of Mixor is determined by the prescribing clinician based on the patient’s blood‑pressure profile, renal function, and other medications. The prescriber selects the appropriate strength and dosing schedule for each individual.

Mixor is not recommended for use during pregnancy unless the potential benefit justifies the risk, as both telmisartan and amlodipine may affect fetal development. Safety during breastfeeding has not been established, so a healthcare professional should be consulted.

To order Mixor, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mixor combines an ARB (telmisartan) with a calcium‑channel blocker (amlodipine), offering additive blood‑pressure reduction compared with either agent alone. This dual‑mechanism approach can be more effective than monotherapy for patients whose hypertension is not controlled by a single drug class.

Mixor tablets should be stored at ambient temperature, below 25 °C, in the original packaging. Keep the container tightly closed, protect from moisture and direct sunlight, and keep out of reach of children.

Mixor is taken orally, usually once daily, with or without food, as directed by a healthcare professional. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically instructed.

Serious risks include angioedema, severe hypotension, liver enzyme elevations, and rare cardiac conduction disturbances. Patients should seek immediate medical attention if they experience swelling of the face or throat, faintness, or unexplained chest pain.

Mixor should be avoided in patients with known hypersensitivity to telmisartan, amlodipine, or any excipients, as well as in those with severe hepatic impairment. Caution is advised for individuals with significant renal dysfunction, uncontrolled heart failure, or pregnant women.